151 related articles for article (PubMed ID: 37119001)
1. An Unusual Case of Hepatocellular Carcinoma in a Healthy Teenager.
Ugonabo O; Pulipati Y; Elghezewi A; Miller V; Logan L; Pramod P
J Investig Med High Impact Case Rep; 2023; 11():23247096231165744. PubMed ID: 37119001
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.
Okada K; Kim YI; Nakashima K; Tada I; Yoshida T; Kobayashi M; Yokoyama S
Surg Today; 1993; 23(7):626-31. PubMed ID: 7690275
[TBL] [Abstract][Full Text] [Related]
3. The Use of Fluorescence
Weiel JJ; Forgo B; Sage J; Rangaswami A; Hazard FK
Ann Clin Lab Sci; 2022 May; 52(3):475-483. PubMed ID: 35777788
[TBL] [Abstract][Full Text] [Related]
4. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
[TBL] [Abstract][Full Text] [Related]
5. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
7. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
Graham RP; Lackner C; Terracciano L; González-Cantú Y; Maleszewski JJ; Greipp PT; Simon SM; Torbenson MS
Hepatology; 2018 Oct; 68(4):1441-1447. PubMed ID: 29222914
[TBL] [Abstract][Full Text] [Related]
8. Case Report of Fibrolamellar Hepatocellular Carcinoma in A 15-Year-old Male.
Alsadery HA; Almaiman H; Alibrah R; Mnayan M; Alblowi A; Alzayyat R; Alshahrani A
Med Arch; 2022 Oct; 76(5):387-390. PubMed ID: 36545449
[TBL] [Abstract][Full Text] [Related]
9. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
10. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
[TBL] [Abstract][Full Text] [Related]
11. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Aby E; Phan J; Truong E; Grotts J; Saab S
J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
J Hepatol; 1994 Dec; 21(6):1006-11. PubMed ID: 7699220
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.
Alqahtani SA; Chan WK; Yu ML
Clin Liver Dis; 2023 May; 27(2):211-223. PubMed ID: 37024203
[TBL] [Abstract][Full Text] [Related]
16. alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.
Govindarajan S; Ashcavai M; Peters RL
Hepatology; 1981; 1(6):628-31. PubMed ID: 6171495
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
18. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
[TBL] [Abstract][Full Text] [Related]
19. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]